To confirm these observations, blood was collected from healthy controls and patients with non–small cell lung cancer (NSCLC) with PD-L1–positive scores and stained with fluorescence-conjugated antibodies for flow cytometry analysis. Here, CD274 is linked to non-small cell lung carcinoma.